Enhanced quadrivalent vaccine against seasonal influenza for the 2022/2023 flu season

Kort beskrivelse

The Norwegian Institute of Public Health (NIPH) would like to procure a enhanced 4-valent vaccine against seasonal influenza for vaccinating nursing home residents aged 65 or older. An enchanced 4-valent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme. The procurement will follow the rules for an open tender contest in accordance with the Public Procurements Act and regulations (FOA) parts 1 and 3, and will be made electronically in the contracting authority's electronic contest management tool, CTM (EU-Supply). The aim is to enter into a contract for the delivery of 40,000 doses of enhanced 4-valent influenza vaccines. The tender documentation specifies the minimum requirements for the vaccine. A contract will be signed with one tenderer.